Corestreet Logo

G1 Therapeutics Inc (GTHX) Insider Trading

Total insider buys:
  • $18,200,044.00
Total insider sells:
  • $65,877,478.52
Most recent insider trade:
  • July 5, 2024
Most active insider trader:
  • Mark A Velleca
Trader NameDateTitleAmountPriceTypeTotal Value
July 5, 2024CEO7,662$2.51Sell$19,231.62
July 5, 2024COO2,475$2.51Sell$6,212.25
July 5, 2024Insider1,337$2.51Sell$3,355.87
July 5, 2024CFO527$2.51Sell$1,322.77
May 23, 2024Insider5,826$4.27Sell$24,877.02
March 18, 2024CFO6,547$3.02Sell$19,771.94
Feb. 12, 2024Insider28,600$4.62Sell$132,132.00
Jan. 4, 2024COO721$2.94Sell$2,119.74
Jan. 4, 2024CFO111$2.94Sell$326.34
Jan. 3, 2024Insider3,019$3.12Sell$9,419.28
Jan. 2, 2024CEO32,983$3.27Sell$107,854.41
Dec. 11, 2023Insider33,839$3.41Sell$115,390.99
July 5, 2023CEO2,719$2.45Sell$6,661.55
July 5, 2023Insider355$2.45Sell$869.75
July 5, 2023COO1,361$2.45Sell$3,334.45
Jan. 5, 2023COO729$5.41Sell$3,943.89
Jan. 4, 2023CFO1,639$5.58Sell$9,145.62
Jan. 4, 2023Insider820$5.58Sell$4,575.60
Jan. 3, 2023CEO32,019$5.85Sell$187,311.15
Oct. 18, 2022Director15,000$11.70Sell$175,500.00
Sept. 20, 2022Director20,000$13.50Sell$270,000.00
Sept. 13, 2022Insider18,000$15.71Sell$282,780.00
Aug. 16, 2022Director80,000$12.64Sell$1,011,200.00
July 5, 2022COO648$5.17Sell$3,350.16
Jan. 5, 2022General Counsel1,445$10.61Sell$15,331.45
Jan. 3, 2022CEO34,125$10.41Sell$355,241.25
July 15, 2021Director10,000$18.49Sell$184,900.00
July 13, 2021Director10,000$19.45Sell$194,500.00
June 17, 2021Director10,000$21.77Sell$217,700.00
June 15, 2021Director10,000$22.39Sell$223,900.00
May 13, 2021Director30,000$19.90Sell$597,000.00
May 11, 2021Director10,000$19.10Sell$191,000.00
April 22, 2021Insider15,000$22.07Sell$331,050.00
April 14, 2021Director10,000$24.53Sell$245,300.00
March 23, 2021Insider15,000$21.94Sell$329,100.00
Feb. 18, 2021Director10,000$26.02Sell$260,200.00
Feb. 16, 2021Director11,040$35.20Sell$388,608.00
Jan. 22, 2021Insider15,000$20.64Sell$309,600.00
Jan. 20, 2021Director10,000$21.51Sell$215,100.00
Dec. 24, 2020Director924$20.10Sell$18,572.40
Dec. 22, 2020Director18,974$20.33Sell$385,741.42
Dec. 17, 2020CEO30,000$19.53Sell$585,900.00
Dec. 15, 2020CEO10,000$19.43Sell$194,300.00
Dec. 10, 2020Director546$20.00Sell$10,920.00
Dec. 10, 2020SVP9,000$20.06Sell$180,540.00
Dec. 8, 2020Director13,161$20.19Sell$265,720.59
Dec. 1, 2020Director520$20.09Sell$10,446.80
Nov. 18, 2020Director50,000$13.50Buy$675,000.00
Sept. 4, 2020General Counsel1,000$14.95Buy$14,950.00
Dec. 26, 2018Director1,420$18.45Buy$26,199.00
First«1 of 2»Last

  • Insiders are both buying and selling G1 Therapeutics Inc stock.

  • The insider traders at G1 Therapeutics Inc are: Mark A Velleca, Rajesh Malik, Jennifer K Moses, Terry L Murdock, Seth Rudnick, John E (Jack) Jr. Bailey, John W V Umstead, Clay Thorp, Medimmune Ventures, Inc., James S Hanson, Andrew Perry, Mark A. Velleca, Fredric N Eshelman, John Demaree, Glenn P Muir, Monica R Thomas, Ra Capital Healthcare Fund Lp, Cynthia Schwalm, Jay Strum, and Barclay A Phillips

  • The most active insider trader at G1 Therapeutics Inc is Mark A Velleca with 19 trades.

  • Clay Thorp has sold the most G1 Therapeutics Inc stock with a total value of $78,716,625.00.

  • Fredric N Eshelman has bought the most G1 Therapeutics Inc stock with a total value of $14,365,000.00.

  • The most recent insider trade for G1 Therapeutics Inc was on July 5, 2024.

  • The single biggest insider buy for G1 Therapeutics Inc was from Ra Capital Healthcare Fund Lp with a total value of $6,000,000.00 on May 22, 2017.

  • The single biggest insider sell for G1 Therapeutics Inc was from Clay Thorp with a total value of $38,400,000.00 on May 30, 2018.